An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Executive vice-president and company group chairman Ryan Weldon will leave, Valeant confirmed late on Friday after inquiries by Reuters. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co. Valeant said Weldon's departure was planned, and takes effect after it completes a $1.4 billion sale of several injectable treatments to Nestle SA . "Although his leadership will be missed, the company has created and developed a strong management team and I am confident Ryan will assist us successfully through this transition period," Pearson said in a statement.
from Business News Headlines - Yahoo! News http://ift.tt/SJ2S4y
via
IFTTT
No comments:
Post a Comment